Peggy Riese Department of Vaccinology and Applied Microbiology Helmholtz Centre for Infection Research Biography Publications Institution JoVE Articles Peggy Riese has not added a biography. If you are Peggy Riese and would like to personalize this page please email our Author Liaison for assistance. Publications Influenza-Activated ILC1s Contribute to Antiviral Immunity Partially Influenced by Differential GITR Expression Frontiers in Immunology. 2018 | Pubmed ID: 29623077 Respiratory Influenza A Virus Infection Triggers Local and Systemic Natural Killer Cell Activation Toll-Like Receptor 7 Frontiers in Immunology. 2018 | Pubmed ID: 29497422 Roads to Advanced Vaccines: Influenza Case Study Microbial Biotechnology. Sep, 2017 | Pubmed ID: 28809451 Blockade of Neutrophil's Chemokine Receptors CXCR1/2 Abrogate Liver Damage in Acute-on-Chronic Liver Failure Frontiers in Immunology. 2017 | Pubmed ID: 28484461 Establishment of a Cohort for Deep Phenotyping of the Immune Response to Influenza Vaccination Among Elderly Individuals Recruited from the General Population Human Vaccines & Immunotherapeutics. 07, 2017 | Pubmed ID: 28394705 Targeted Antigen Delivery to Dendritic Cells Elicits Robust Antiviral T Cell-mediated Immunity in the Liver Scientific Reports. Mar, 2017 | Pubmed ID: 28266658 Motivations for (non)participation in Population-based Health Studies Among the Elderly - Comparison of Participants and Nonparticipants of a Prospective Study on Influenza Vaccination BMC Medical Research Methodology. 02, 2017 | Pubmed ID: 28148221 A New RNA-Based Adjuvant Enhances Virus-Specific Vaccine Responses by Locally Triggering TLR- and RLH-Dependent Effects Journal of Immunology (Baltimore, Md. : 1950). 02, 2017 | Pubmed ID: 28077601 Deletion of Irf3 and Irf7 Genes in Mice Results in Altered Interferon Pathway Activation and Granulocyte-Dominated Inflammatory Responses to Influenza A Infection Journal of Innate Immunity. 2017 | Pubmed ID: 27811478 Activation of Innate and Adaptive Immunity by a Recombinant Human Cytomegalovirus Strain Expressing an NKG2D Ligand PLoS Pathogens. Dec, 2016 | Pubmed ID: 27907183 New Horizons in the Development of Novel Needle-Free Immunization Strategies to Increase Vaccination Efficacy Current Topics in Microbiology and Immunology. 2016 | Pubmed ID: 27370343 Rodents As Pre-clinical Models for Predicting Vaccine Performance in Humans Expert Review of Vaccines. 2015 | Pubmed ID: 26268433 Type I Interferon Released by Myeloid Dendritic Cells Reversibly Impairs Cytomegalovirus Replication by Inhibiting Immediate Early Gene Expression Journal of Virology. Oct, 2015 | Pubmed ID: 26202227 Induction of CD4(+) and CD8(+) Anti-tumor Effector T Cell Responses by Bacteria Mediated Tumor Therapy International Journal of Cancer. Oct, 2015 | Pubmed ID: 25868911 Activated NKT Cells Imprint NK-cell Differentiation, Functionality and Education European Journal of Immunology. Jun, 2015 | Pubmed ID: 25808315 Intranasal Formulations: Promising Strategy to Deliver Vaccines Expert Opinion on Drug Delivery. Oct, 2014 | Pubmed ID: 24962722 Vaccine Adjuvants: Key Tools for Innovative Vaccine Design Current Topics in Medicinal Chemistry. 2013 | Pubmed ID: 24066891 A Pegylated Derivative of Alpha-galactosylceramide Exhibits Improved Biological Properties Journal of Immunology (Baltimore, Md. : 1950). Aug, 2007 | Pubmed ID: 17675464 The Bacterial Second Messenger CdiGMP Exhibits Promising Activity As a Mucosal Adjuvant Clinical and Vaccine Immunology : CVI. Aug, 2007 | Pubmed ID: 17567766 The Bacterial Second Messenger Cyclic DiGMP Exhibits Potent Adjuvant Properties Vaccine. Feb, 2007 | Pubmed ID: 17187906 Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development Darío Lirussi1, Thomas Ebensen1, Kai Schulze1, Elena Reinhard1, Stephanie Trittel1, Peggy Riese1, Blair Prochnow1, Carlos A. Guzmán1 1Department of Vaccinology and Applied Microbiology, Helmholtz Centre for Infection Research JoVE 57401 Medicina
Rapid In Vivo Assessment of Adjuvant's Cytotoxic T Lymphocytes Generation Capabilities for Vaccine Development Darío Lirussi1, Thomas Ebensen1, Kai Schulze1, Elena Reinhard1, Stephanie Trittel1, Peggy Riese1, Blair Prochnow1, Carlos A. Guzmán1 1Department of Vaccinology and Applied Microbiology, Helmholtz Centre for Infection Research JoVE 57401 Medicina